Pleural mesothelioma remains one of the most challenging thoracic malignancies to diagnose and treat. Due to its long latency period and non-specific presentation, most patients are diagnosed at an advanced stage, resulting in a 5-year survival rate of less than 10%. While surgery was once a standard approach, it is now reserved for a select subset of patients. Platinum-based chemotherapy remains a cornerstone of therapy but is frequently limited by high relapse rates. Fortunately, the treatment landscape is rapidly evolving with the emergence of novel therapies that promise to be both more tolerable and effective. In this educational program, expert faculty will explore the challenges hindering timely diagnosis, evaluate the limitations of current treatment options, and analyze the latest clinical evidence for emerging novel therapies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
82% of listed courses are free
78 of 95 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Preventive Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedSep 30, 2026
-
Last day to claim creditOct 1, 2027 12 months left
-
ScientiaCME Combating rapid growth with durable response: navigating emerging therapies in extensive stage SCLC
-
Efficient CME, CME Outfitters, LLC How Do I Manage Advanced Biliary Tract Cancer (BTC)? An Exploration of Expert Practice Patterns
-
Answers in CME Inc. (AiCME) Oncology – Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary NECs
-
Haymarket Medical Education Emerging Data and Evolving Guidelines: A Patient-Centered Approach to Evidence-Based Treatment for Aortic Stenosis
-
CancerNet +1 Advances in the Treatment of Myelofibrosis: Clinical Trial Data of Next Generation Therapeutics
-
CanRehab +1 Cancer Rehabilitation: Exercise Training for Oncology Care Teams
